| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,629 |
4,427 |
$219K |
| 87428 |
|
1,072 |
1,058 |
$61K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
387 |
377 |
$33K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
792 |
785 |
$8K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
71 |
65 |
$6K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
116 |
106 |
$4K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
44 |
41 |
$4K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
29 |
29 |
$4K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
31 |
27 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
86 |
86 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
76 |
67 |
$1K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
13 |
13 |
$829.42 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
15 |
15 |
$742.86 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
16 |
16 |
$589.05 |
| 81002 |
|
172 |
171 |
$359.92 |
| 87070 |
|
16 |
15 |
$294.68 |
| 81025 |
|
57 |
56 |
$266.70 |